Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest pain.

Granér M, Tikkanen E, Rimpilä O, Tikkanen H, Ripatti S, Lokki ML, Nieminen MS, Taskinen MR, Sinisalo J.

Ann Med. 2013 Jun;45(4):322-7. doi: 10.3109/07853890.2013.783996. Epub 2013 May 8.

PMID:
23651064
2.

Increased circulating soluble LR11 in patients with acute coronary syndrome.

Ogita M, Miyauchi K, Dohi T, Tsuboi S, Miyazaki T, Yokoyama T, Yokoyama K, Shimada K, Kurata T, Jiang M, Bujo H, Daida H.

Clin Chim Acta. 2013 Jan 16;415:191-4. doi: 10.1016/j.cca.2012.10.047. Epub 2012 Nov 2.

PMID:
23127357
3.

Elevated serum myeloperoxidase activities are significantly associated with the prevalence of ACS and High LDL-C levels in CHD patients.

Liu C, Xie G, Huang W, Yang Y, Li P, Tu Z.

J Atheroscler Thromb. 2012;19(5):435-43. Epub 2012 Jan 11.

4.

Pentraxin 3 as a biomarker for acute coronary syndrome: comparison with biomarkers for cardiac damage.

Kume N, Mitsuoka H, Hayashida K, Tanaka M.

J Cardiol. 2011 Jul;58(1):38-45. doi: 10.1016/j.jjcc.2011.03.006. Epub 2011 May 26.

5.

Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.

Roman RM, Camargo PV, Borges FK, Rossini AP, Polanczyk CA.

Coron Artery Dis. 2010 May;21(3):129-36. doi: 10.1097/MCA.0b013e328333f50d.

PMID:
20305551
6.
7.

Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain.

Inoue K, Suwa S, Ohta H, Itoh S, Maruyama S, Masuda N, Sugita M, Daida H.

Circ J. 2011;75(12):2813-20. Epub 2011 Sep 21.

8.

Myeloperoxidase and C-reactive protein in patients with cocaine-associated chest pain.

O'Conor K, Chang AM, Wu AH, Hollander JE.

Am J Emerg Med. 2013 Apr;31(4):664-9. doi: 10.1016/j.ajem.2012.11.026. Epub 2013 Feb 4.

PMID:
23380098
9.

Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.

Jabor B, Choi H, Ruel I, Hafiane A, Mourad W, Genest J.

Can J Cardiol. 2013 Dec;29(12):1679-86. doi: 10.1016/j.cjca.2013.09.026. Epub 2013 Oct 2.

PMID:
24267807
10.

[Myeloperoxidase in the plasma of patients with acute coronary syndrome].

Ouyang M, Yang K, Zhang MX, Jiang WH, Cao Y, Wang JG, Gao YD.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006 Dec;31(6):901-5. Chinese.

11.

Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum.

Peacock WF, Nagurney J, Birkhahn R, Singer A, Shapiro N, Hollander J, Glynn T, Nowak R, Safdar B, Miller C, Peberdy M, Counselman F, Chandra A, Kosowsky J, Neuenschwander J, Schrock J, Plantholt S, Lewandrowski E, Wong V, Kupfer K, Diercks D.

Am Heart J. 2011 Nov;162(5):893-9. doi: 10.1016/j.ahj.2011.08.017.

PMID:
22093206
12.

Circulating soluble SR-PSOX/CXCL16 as a biomarker for acute coronary syndrome -comparison with high-sensitivity C-reactive protein.

Mitsuoka H, Toyohara M, Kume N, Hayashida K, Jinnai T, Tanaka M, Kita T.

J Atheroscler Thromb. 2009 Oct;16(5):586-93. Epub 2009 Sep 3.

13.
14.

The role of myeloperoxidase (MPO) for prognostic evaluation in sensitive cardiac troponin I negative chest pain patients in the emergency department.

Searle J, Shih J, Muller R, Vollert JO, Müller C, Danne O, Datwyler S, Möckel M.

Eur Heart J Acute Cardiovasc Care. 2013 Sep;2(3):203-10. doi: 10.1177/2048872613484688.

15.
16.

Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.

Yunoki K, Naruko T, Inaba M, Inoue T, Nakagawa M, Sugioka K, Ohsawa M, Iwasa Y, Komatsu R, Itoh A, Haze K, Yoshiyama M, Becker AE, Ueda M.

Atherosclerosis. 2013 Dec;231(2):308-14. doi: 10.1016/j.atherosclerosis.2013.08.037. Epub 2013 Oct 8.

PMID:
24267244
17.

Platelet glycoprotein VI (GPVI) for early identification of acute coronary syndrome in patients with chest pain.

Bigalke B, Haap M, Stellos K, Geisler T, Seizer P, Kremmer E, Overkamp D, Gawaz M.

Thromb Res. 2010 May;125(5):e184-9. doi: 10.1016/j.thromres.2010.01.005. Epub 2010 Feb 1.

PMID:
20122713
19.

Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes.

Sawicki M, Sypniewska G, Kozinski M, Gruszka M, Krintus M, Obonska K, Pilaczynska-Cemel M, Kubica J.

Eur J Clin Invest. 2011 Jun;41(6):667-71. doi: 10.1111/j.1365-2362.2010.02457.x. Epub 2011 Jan 12.

PMID:
21226709
20.

Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomography.

Kobayashi N, Takano M, Hata N, Kume N, Yamamoto M, Yokoyama S, Shinada T, Tomita K, Shirakabe A, Otsuka T, Seino Y, Mizuno K.

Int J Cardiol. 2013 Oct 9;168(4):3217-23. doi: 10.1016/j.ijcard.2013.04.110. Epub 2013 Apr 28.

PMID:
23632121

Supplemental Content

Support Center